Original Source(s)
Related Content
Makary Resigns as FDA Commissioner Following Policy Disputes
Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization
May 12, 2026
-
2 min
FDA Expands Afrezza to Pediatric Diabetes
The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.
May 29, 2026
-
3 min